# Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

> **NCT01709136** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Pittsburgh** · enrollment: 3 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT01709136
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Sirolimus usage discontinued since black box warning
- **Last updated:** 2023-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709136, "Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01709136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*